Statement from Center for Drug Evaluation and Research Director Janet Woodcock regarding safety concerns related to investigational use of Keytruda in multiple myeloma

August 31, 2017 – Clinical trials play a critically important role in bringing to market innovative new therapies for patients facing life-threatening disease. It is an exciting time for medical innovation. Already, clinical trials have helped realize exciting and meaningful advancements for patients with critical diseases, like cancer, and thousands of clinical trials are currently underway looking at experimental therapies, combinations of therapies and new uses for … (leggi tutto)